Vessel labeling with anti-CD31 antibody in BC histological slides revealed a remarkable decrease in the number of CD31-positive cells compared to DOX (Figure 5A and Supplementary Figure 6), suggesting a role of the HFn-DOX-promoted antiangiogenic effect on the inhibition of tumor progression and diffusion. The gene discussed is PECAM1; the disease is breast cancer.